Common Stock, Shares, Outstanding of Protara Therapeutics, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Protara Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Protara Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 53,587,260, a 53% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Protara Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 53,587,260 +18,542,488 +53% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 38,587,260 +17,957,488 +87% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 38,581,863 +27,216,960 +239% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 38,577,813 +27,143,976 +237% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 35,044,772 +23,679,869 +208% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 20,629,772 +9,264,869 +82% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 11,364,903 +56,941 +0.5% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 11,433,837 +127,084 +1.1% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 11,364,903 +97,514 +0.86% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 11,364,903 +97,514 +0.86% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 11,307,962 +50,785 +0.45% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 11,306,753 +54,826 +0.49% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 11,267,389 +31,658 +0.28% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 11,267,389 +31,658 +0.28% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 11,257,177 +23,321 +0.21% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 11,251,927 +23,321 +0.21% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 11,235,731 +23,891 +0.21% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 11,235,731 +713,891 +6.8% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 11,233,856 +5,390,653 +92% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 11,228,606 +5,385,403 +92% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 11,211,840 +8,584,307 +327% 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q3 2020 10,521,840 -9,063,554 -46% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 5,843,203 -13,742,191 -70% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 5,843,203 -13,742,191 -70% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 2,627,533 +2,146,442 +446% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 19,585,394 +364,102 +1.9% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 19,585,394 +1,858,681 +10% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 19,585,394 +1,910,665 +11% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 481,091 -17,193,638 -97% 31 Dec 2018 10-K 20 Mar 2020 2019 FY
Q3 2018 19,221,292 +1,601,874 +9.1% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 17,726,713 +107,295 +0.61% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 17,674,729 +903,657 +5.4% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 17,674,729 +1,071,170 +6.5% 31 Dec 2017 10-K 13 Mar 2019 2018 FY
Q3 2017 17,619,418 +1,036,419 +6.2% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 17,619,418 +1,044,736 +6.3% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 16,771,072 +263,178 +1.6% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 16,603,559 +102,059 +0.62% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 16,582,999 +103,491 +0.63% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 16,574,682 +116,205 +0.71% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 16,507,894 +59,203 +0.36% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 16,501,500 +53,045 +0.32% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 16,479,508 +16,238,894 +6749% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 16,458,477 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 16,448,691 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 16,448,455 +16,208,550 +6756% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q3 2014 240,614 30 Sep 2014 10-Q 25 Nov 2014 2014 Q3
Q4 2013 239,905 31 Dec 2013 10-K 20 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.